Sanofi Stops Supplying Hydroxychloroquine to COVID-19 Patients in Clinical Trials

Eric Volkman, The Motley Fool
Sanofi Stops Supplying Hydroxychloroquine to COVID-19 Patients in Clinical Trials

The malaria drug is quickly falling out of favor with the medical community as a potential treatment for the disease.